[contact-form-7 id="15592" title="Tell me more"]

Contact Next Edge Capital

1 Toronto Street, Suite 200
Toronto, ON M5C 2V6

Telephone: 416.775.3600
Toll-free: 1.877.860.1080
Fax: 416.775.3601
Email: info@nextedgecapital.com

Next Edge Capital Corp. Announces Proposed Fund Merger

Next Edge Capital is pleased to announce the next phase of enhancements to its investment fund platform. Subject to all required unitholder and regulatory approvals, the Next Edge Bio-Tech Plus Fund will be the Next Edge Biotech and Life Sciences Opportunities Fund....

Read More
Canada Strikes Deals to Get Vaccine Supply

Eden Rahim, the Portfolio Manager of Next Edge Bio-Tech Plus Fund, joins a conversation with Jon Erlichman on BNN Bloomberg to discuss the Canadian government's deals with BioNTech/Pfizer and Moderna to gain access to their possible vaccines....

Read More
Biotech Stocks Soar as Race for COVID-19 Vaccine

Eden Rahim, the Portfolio Manager of Next Edge Bio-Tech Plus Fund, joins BNN Bloomberg and discusses the investing frenzy in biotech stocks and two companies he believes stand out among the crowd in the race for a COVID-19 vaccine....

Read More
Could Take 2-3 Years to Get Vaccine for Coronavirus

Eden Rahim, portfolio manager and options strategist at Next Edge Capital joins BNN Bloomberg to talk about the race to cure the coronavirus. More than 20 potential vaccines are being worked on globally according to the World Health Organization....

Read More
Biotech Sector is Deeply Undervalued

Eden Rahim, portfolio manager and options strategist at Next Edge Capital, says after five years of sideways action the U.S. biotech sector has sprung to life. He says now is a good time for investors to make a move, calling the sector "deeply undervalued."...

Read More
Is weed a responsible investment?

Eden Rahim, portfolio manager and options strategist at Next Edge Capital, discusses whether pharmaceutical companies should be nervous as the cannabis sector makes gains, as some in the burgeoning industry have implied....

Read More
How to crush the biotech market

Eden Rahim, portfolio manager and options strategist at Next Edge Capital, discusses whether pharmaceutical companies should be nervous as the cannabis sector makes gains, as some in the burgeoning industry have implied....

Read More